Elan Launches Manufacturing Business

Elan Drug Technologies, a business unit of Elan Corp. will launch its Manufacturing Services business at CPhI in Paris on October 5th (booth 5D63). The company will highlight services it provides to pharmaceutical companies, including drug product optimization, scale-up and commercial scale manufacturing of solid oral dosage forms.

“We are very excited to be launching our Manufacturing Services business at this worldwide event. For more than 40 years, Elan Drug Technologies has been a leading provider of drug delivery technologies and dosage form development for the pharmaceutical market,” said Shane Cooke, executive vice president and head of Elan Drug Technologies. “We look forward to expanding our services in commercial scale-up and manufacturing, where we can offer a broad range of manufacturing solutions for our clients from our facilities in Europe and the U.S.”

In conjunction with the launch of the new business, Philip Pratten has been appointed vice president, Manufacturing Services Operations. Mr. Pratten has almost 30 years of experience in the pharma industry and has held positions with Catalent Pharma Solutions, GlaxoWellcome and the Wellcome Foundation.